Skip to content

Prognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2

IPrognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04672343
Acronym
CodePRONUT
Enrollment
426
Registered
2020-12-17
Start date
2020-10-19
Completion date
2021-10-18
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2

Brief summary

Mortality due to Covid-19 is much higher in the elderly. There are several reasons for the vulnerability of the elderly to the coronavirus: a less efficient immune system, underlying chronic conditions, less protected living conditions. They may also present a poor nutritional state and/or degraded metabolic reserves aggravating an underlying state of frailty. The prevalence of the risk of undernutrition in elderly patients with COVID-19 is high. The evolution of the nutritional status of people aged 70 years or older infected with SARS-Cov-2 is not yet well known. The prognosis of these patients could depend on their nutritional status at the time of the disease. In view of the lack of data, it would be interesting to compare the risk of mortality based on nutritional status in individuals with vs. those without COVID-19.

Interventions

OTHERData collection

from D0 to hospital discharge

OTHERQuerying the INSEE database

Vital status at 3 months and 12 months

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* SARS-CoV-2 test positive (positive PCR test or evocative CT scan) or negative (with clinical suspicion of COVID, negative PCR test and non-evocative CT scan) * Age ≥ 70 years old * Hospitalization at Dijon University Hospital * Person or legal representative has not stated their opposition to inclusion in the study after being informed

Exclusion criteria

* Person subject to a measure of judicial safeguard * Non-affiliated or non-beneficiary of national health insurance

Design outcomes

Primary

MeasureTime frame
Deathto 3 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026